Fig. 1

Cell metabolism assay by MTT analysis of IPC-366 control cells and those treated with 1–10 µg/mL of DOXO for 24 (a), 48 (b) and 72 h (c). Growth curve analysis was evaluated in 24 h, 48 h, and 72 h (d). DOXO: doxorubicin; AMCs: amniotic membrane cells. Data are averaged (n ≥ 04 ± SEM), performed with one-way analysis of variance (ANOVA) as a Bonferroni pos-hoct test, *p < 0.05, **p < 0.01, ***p < 0.001